Line K. Vibholm

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus et al. · EBioMedicine · 2021 · 168 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen et al. · Clinical Infectious Diseases · 2017 · 146 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals

Line K. Vibholm, Christina Valbirk Konrad, Mariane Høgsbjerg Schleimann et al. · AIDS · 2019 · 94 citations

Life Sciences, Immunology, Pharmacology +17

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

Stine Sofie Frank Nielsen, Line K. Vibholm, Ida Monrad et al. · EBioMedicine · 2021 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H. Pahus et al. · Nature Medicine · 2023 · 83 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16